Expérimentation préclinique et recherche clinique

64Cu-ATSM as a therapeutic agent in solid tumor? preliminary results of a whole body human dosimetry study OP-0360.
Varmenot N, Colombié M, Rousseau C, Haddad F, Ferrer L
EANM’21 34th Annual congress of the European Association of Nuclear Medicine, édition virtuelle, 20-23 octobre 2021

Preclinical study of Targeted Alpha Therapy using 211At-labeled phenylalaline derivative in a syngeneic Multiple Myeloma model OP-0106.
Gaschet J, Echeynne R, Chouin N, Gazzola S, Guérard F, Gouard S, Marionnaud-Lambot S, Maubert AL, Alliot C, Hofgaard PO, Bogen B, Yan E, Haddad F, Kraeber-Bodéré F, Wheatcroft M, Gestin JF, Chérel M
EANM’21 34th Annual congress of the European Association of Nuclear Medicine, édition virtuelle, 20-23 octobre 2021

Preliminary evaluation of 64Cu-ATSM as a tracer of predictive assessment of neoadjuvant treatment response in locally advanced rectal cancer OP-0062.
Colombié M, Ferrer L , Lacombe M, Fleury V, le Thiec M, Morel A, Maugerat B, Rusu D, Varmenot N, Tremolieres P, Allam N, Rio E, Guimas V, Masson I, Senellart H, Hiret S, Salaun PY, Campion L, Vidal A, Haddad F, Rauscher A, Kraeber-Bodéré F, Bourgeois M, Rousseau C
EANM’21 34th Annual congress of the European Association of Nuclear Medicine, édition virtuelle, 20-23 octobre 2021

In vivo theranostic evaluation of a 64Cu-radiolabelled antibody in a murine model of multiple myeloma
Métivier C, Remaud-Le Saëc P, Marionneau-Lambot S, Davodeau F, Chauvet C, Saï-Maurel C, Hofgaard PO, Bogen B, Tripier R, Haddad F, Gaschet J, Chérel M, Chouin N, Faivre-Chauvet A, Rbah-Vidal L
14th Workshop Adaptation of the tumour and its ecosystem to radiotherapies, Le Bono, France, 22-25 septembre 2021

Interest of whole-body immuno-SPECT-CT for canine diffuse large B-cell lymphoma (DLBCL) staging before radioimmunotherapy (RIT) using an anti-CD22 monoclonal antibody
Etienne F, Nguyen F, Becavin S, Bodet-Milin C, Bourgeois M, Vidal A, Abadie J, Bouhsina N, Davodeau F, Ibisch C, Chouin N
European Society of Veterinary Oncology (ESVONC) Conference, virtual edition, 28-29 mai 2021

Conférence annuelle ESVONC (European Society of Veterinary Oncology) (Lyon, France) – Avril 2017 – “ Targeting CD22 in spontaneous diffuse large B-cell lymphoma bearing dogs : quantitative imaging (immuno-SPECT) and dosimetric approach in preparation of radioimmunotherapy (RIT) “ F. Morio1, N. Chouin1,2, F. Nguyen1, M. Berthaud2, M. Fusellier3, C. Bodet-Milin2,4, M. Roussel1, S. Becavin1, J. Abadie1, L. Ferrer2,5, C. Ibisch1,2, F. Davodeau2

Conférence EANM 2017 (Vienne, Autriche)- Octobre 2017 – « B-cell lymphoma radioimmunotherapy : effect of co-infusion of cold and radiolabelled antibody on absorbed doses to healthy tissues and tumours, a preclinical study in dogs ». F. Morio1,2, C. Ibisch1,2, F. Nguyen1,3, M. Berthaud2, J. Abadie1,3, A. Vidal5, M. Bourgeois2,4,5, K. Bernardeau7, S. Becavin1, M. Roussel1, L. Ferrer2,6, C. Bodet-Milin2,4, N. Chouin1,2, F. Davodeau2

J. Barbet, Conf invité Pretargeting in the Context of Theranostics and Companion Diagnostics, CME 5 : Theranostics and Companion Drugs, EANM, Vienna (Autriche) October 21-25, 2017

Chérel M, Anticorps monoclonaux : mise en place d’une filière nationale : le point de vue d’Arronax, 11^e Journées du cancéropole Grand Ouest, Vannes, France, June 29-30 2017

PET Imaging criteria in Myeloma, Kraeber-Bodéré F, 7th international workshop on PET in lymphoma and myeloma PIM, Menton, France, October 5-6 2018 (invited)

PET Imaging criteria in Myeloma, Bodet-Milin C, 7th international workshop on PET in lymphoma and myeloma PIM, Menton, France, October 5-6 2018 (invited)

Efficacy of Astatine-211 radioimmunotherapy of Multiple Myeloma using an anti-mCD138 monoclonal antibody in a syngeneic murine model (OP-508). Gouard S, Chalopin B, Maurel C, Guérard F, Navarro L, Gestin JF, Chouin N, Haddad F, Alliot C, Kraeber-Bodéré F, Davodeau F, Chérel M . EANM’18 31th Annual congress of the European Association of Nuclear Medicine, Dusseldorf, Germany, oct 13-17 2018

Biodistribution, Imaging and Metabolism Studies of 64-Copper Radiolabelled Monoclonal Antibody: Comparison of DOTA and TE1PA Chelating Agents in a Murine Model of Multiple Myeloma (OP-375). Navarro AS, Le Bihan T, Le Saëc P, Gouard S, Le Bris N, Bailly C, Saï-Maurel C, Chalopin B, Gestin JF, Chérel M, Tripier R, Faivre-Chauvet A. EANM’18 31th Annual congress of the European Association of Nuclear Medicine, Dusseldorf, Germany, oct 13-17 2018

PET Imaging of Multiple Myeloma: Comparison of ⁸⁹Zr- and ⁶⁴Cu-labeled anti-CD138 Conjugates to ⁶⁴CuCl2 and ¹⁸F-FDG in a Preclinical Syngeneic Model (OP-040). Bailly C, Gouard S, Chalopin B, Carlier T, Maurel C, Remaud-Le Saëc P, Bourgeois M, Chouin N, Tripier R, Haddad F, Faivre-Chauvet A, Kraeber-Bodere F, Bodet-Milin C, Cherel M . EANM’18 31th Annual congress of the European Association of Nuclear Medicine, Dusseldorf, Germany, oct 13-17 2018

Preliminary results of ⁶⁸Ga-PSMA PET/CT prospective study in prostate cancer occult recurrence patients: diagnostic performance and impact on therapeutic decision-making (OP-042). Rousseau C, Le Thiec M, Ferrer L, Rusu D, Rauscher A, Maucherat B, Frindel M, Baumgartner P, Fleury V, Denis V, Varmenot N, Debeaupuis E, Campion L, Kraeber-Bodéré F . EANM’18 31th Annual congress of the European Association of Nuclear Medicine, Dusseldorf, Germany, oct 13-17 2018

Why should we take care about occupational dosimetric impact when routine use of gallium-68 in nuclear medicine? A preliminary study (OP-238). Varmenot N, Ferrer L, Frindel M, Rauscher A, Baumgartner P, Delaunay F, Mathey A, Pitel C, Zulian H, Kraeber-Bodéré F, Denis A, Rousseau C . EANM’18 31th Annual congress of the European Association of Nuclear Medicine, Dusseldorf, Germany, oct 13-17 2018